These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9590125)

  • 1. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma.
    Toyota N; Strebel FR; Stephens LC; Matsuda H; Oshiro T; Jenkins GN; Bull JM
    Int J Cancer; 1998 May; 76(4):499-505. PubMed ID: 9590125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-duration, mild whole body hyperthermia with cisplatin: tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma.
    Toyota N; Strebel FR; Stephens LC; Matsuda H; Bull JM
    Int J Hyperthermia; 1997; 13(5):497-506. PubMed ID: 9354934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of altered duration of 41.5 degrees C whole body hyperthermia in combination with cis-diamminedichloroplatinum (II) on tumor and normal tissue apoptosis and tumor response in rats.
    Toyota N; Strebel FR; Stephens LC; Rowe W; Matsuda H; Oshiro T; Jenkins GN; Bull JM
    Oncol Rep; 1998; 5(5):1231-6. PubMed ID: 9683841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long duration-mild whole body hyperthermia of up to 12 hours in rats: feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: implications for adjuvant therapy.
    Matsuda H; Strebel FR; Kaneko T; Danhauser LL; Jenkins GN; Toyota N; Bull JM
    Int J Hyperthermia; 1997; 13(1):89-98. PubMed ID: 9024930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases.
    Sumiyoshi K; Strebel FR; Rowe RW; Bull JM
    Int J Hyperthermia; 2003; 19(2):103-18. PubMed ID: 12623634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats.
    Sakaguchi Y; Makino M; Kaneko T; Stephens LC; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
    Cancer Res; 1994 Apr; 54(8):2223-7. PubMed ID: 8174130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
    Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
    Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
    Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
    Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
    Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM
    Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs.
    Page RL; Thrall DE; George SL; Price GS; Heidner GL; McEntee MC; Novotney CA; Hauck ML; Dewhirst MW
    Int J Hyperthermia; 1992; 8(6):761-9. PubMed ID: 1479202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
    Los G; van Vugt MJ; Pinedo HM
    Br J Cancer; 1994 Feb; 69(2):235-41. PubMed ID: 8297720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
    Murthy MS; Rao LN; Khandekar JD; Scanlon EF
    Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.
    van Wijk FH; Aapro MS; Bolis G; Chevallier B; van der Burg ME; Poveda A; de Oliveira CF; Tumolo S; Scotto di Palumbo V; Piccart M; Franchi M; Zanaboni F; Lacave AJ; Fontanelli R; Favalli G; Zola P; Guastalla JP; Rosso R; Marth C; Nooij M; Presti M; Scarabelli C; Splinter TA; Ploch E; Beex LV; ten Bokkel Huinink W; Forni M; Melpignano M; Blake P; Kerbrat P; Mendiola C; Cervantes A; Goupil A; Harper PG; Madronal C; Namer M; Scarfone G; Stoot JE; Teodorovic I; Coens C; Vergote I; Vermorken JB;
    Ann Oncol; 2003 Mar; 14(3):441-8. PubMed ID: 12598351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats.
    Sakaguchi Y; Stephens LC; Makino M; Kaneko T; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
    Cancer Res; 1995 Nov; 55(22):5459-64. PubMed ID: 7585616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.
    Xu Y; Choi J; Hylander B; Sen A; Evans SS; Kraybill WG; Repasky EA
    Int J Hyperthermia; 2007 Sep; 23(6):513-27. PubMed ID: 17952765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
    Ohno S; Strebel FR; Stephens LC; Siddik ZH; Baba H; Makino M; Khokhar AR; Bull JM
    Br J Cancer; 1993 Sep; 68(3):469-74. PubMed ID: 8353037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.
    Baba H; Stephens LC; Strebel FR; Siddik ZH; Newman RA; Ohno S; Bull JM
    Cancer Res; 1991 Jul; 51(13):3568-77. PubMed ID: 1905199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.
    Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X
    Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
    Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
    J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.